Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been diagnosed with Type 1 diabetes for at least one year
- People currently managing their diabetes using multiple daily insulin injections, an insulin pump, or an automated insulin delivery system
- People whose HbA1c (a measure of average blood sugar levels over roughly 3 months) is below 9.0%
- The trial aims to include roughly equal numbers of male and female participants, and roughly equal numbers of people using insulin pumps versus multiple daily injections
Who may not be able to join:
- People who have gastroparesis (a condition where the stomach empties too slowly)
- People with significant heart rhythm problems
- People with serious diabetes-related complications affecting the kidneys (with kidney function below a certain level) or severe eye disease affecting the blood vessels
- People who have been diagnosed with epilepsy
- People who are pregnant or currently breastfeeding
- People who experienced a severe low blood sugar episode within one month before joining the trial
- People who have had a serious heart or blood vessel event, or who have low potassium levels in their blood, within three months before joining the trial
- People whose diabetes treatment is expected to change during the trial period
- People who are not able to give informed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Remi Rabasa-Lhoret, IRCM
Phone: 514-987-5643
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Hypoglycemia Prevention with 16g CHO at 5.0 mmol/L
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.